<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parry, Nicola</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Gaita, Dan</style></author><author><style face="normal" font="default" size="100%">Gamra, Habib</style></author><author><style face="normal" font="default" size="100%">Heagerty, Tony</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Perspectives in the Management of Patients with DM and CVD</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-10-27 10:52:03</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">25-26</style></pages><abstract><style  face="normal" font="default" size="100%">The early identification of diabetes and cardiovascular disease (CVD) is essential to establish prevention strategies, which should be based on total risk for CVD. In patients with diabetes and hypertension, the current evidence supports a treatment goal of 140.90 mmHg. Coronary artery bypass grafting surgery is the optimal revascularization strategy in patients with diabetes, based on data from the FREEDOM trial.</style></abstract><number><style face="normal" font="default" size="100%">16</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>